Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Bitcoin Well (V.BTCW) Reports Q1 2024 Financial Results (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Collplant Biotechnologies Ltd CLGN

Healthcare Biotechnology
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I... see more

Recent & Breaking News (NDAQ:CLGN)

CollPlant Partners in the Advanced Regenerative Manufacturing Institute

PR Newswire January 6, 2020

CollPlant Publishes Letter to Shareholders

PR Newswire December 19, 2019

CollPlant Reports Third Quarter 2019 Financial Results and Provides Business Update

PR Newswire November 29, 2019

CollPlant CEO Yehiel Tal Appointed to Serve on International Society for Biofabrication's Industry Relations Committee

PR Newswire October 22, 2019

CollPlant Reports Second Quarter 2019 Financial Results and Provides Business Update

PR Newswire September 26, 2019

CollPlant Biotechnologies Closes on $5.5 Million Financing

PR Newswire September 9, 2019

CollPlant Biotechnologies to Present at the 21st Annual Rodman & Renshaw Global Investment Conference

PR Newswire September 5, 2019

CollPlant Biotechnologies Raising $5.5 Million

PR Newswire September 3, 2019

iBio Inks 3D Bioprinting Agreement

GlobeNewswire August 19, 2019

CollPlant is Developing 3D-bioprinted Implants for Regeneration of Breast Tissue

PR Newswire August 5, 2019

CollPlant Announces Corporate Name Change to CollPlant Biotechnologies to Better Reflect Its Business

PR Newswire June 20, 2019

Clinical Results From CollPlant's Advanced Wound Care Product VergenixFG to Be Presented at European Wound Management Association Conference

PR Newswire June 4, 2019

CollPlant Reports First Quarter 2019 Financial Results and Provides Business Update

PR Newswire May 30, 2019

CollPlant Presents Its rhCollagen-based BioInks for 3D Bioprinting of Tissues and Organs at TERMIS Annual Meeting in Rhodes, Greece

PR Newswire May 28, 2019

CollPlant Launches New HQ and R&D Center in Israel

PR Newswire May 22, 2019

CollPlant Announces Publication of Study in Science Translational Medicine Showing Composite Matrix Based on rhCollagen, Ceramics and Bone Morphogenic Protein Led to Bone Growth Superior to Standard of Care

PR Newswire April 24, 2019

CollPlant to Present at ThinkEquity Conference on May 2, 2019 in New York City

PR Newswire April 23, 2019

CollPlant Reports Fourth Quarter and Year End 2018 Financial Results and Provides Business Update

PR Newswire April 1, 2019

CollPlant Renews Distribution Agreement for Its Soft Tissue Repair Product Vergenix™STR With Arthrex a World Leader in Orthopedics

PR Newswire March 18, 2019

Study Published in Wounds Journal Shows Remarkable Wound Closure Performance With CollPlant's VergenixFG in the Treatment of Chronic Wounds With a 94% Median Wound Area Reduction Within 4-weeks

PR Newswire March 11, 2019